Clinical trials recruiting for Chronic Hepaititis B

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
  NCT07200193 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 4 locations
• ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)
  NCT07741461 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
  NCT07328711 · Phase: Early Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Chronic Hepaititis B often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Chronic Hepaititis B trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.